Phantom validation of quantitative susceptibility and dynamic contrast‐enhanced permeability MR sequences across instruments and sites-Reference-Cited by-同舟云学术

Phantom validation of quantitative susceptibility and dynamic contrast‐enhanced permeability MR sequences across instruments and sites

Published:2019-09-12 Issue:4 Volume:51 Page:1192-1199
ISSN:1053-1807
Container-title:Journal of Magnetic Resonance Imaging
language:en
Short-container-title:J Magn Reson Imaging

Author:

Hobson Nicholas¹^ORCID,Polster Sean P.¹,Cao Ying¹,Flemming Kelly²,Shu Yunhong³,Huston John³,Gerrard Chandra Y.⁴,Selwyn Reed⁴,Mabray Marc⁴,Zafar Atif⁵,Girard Romuald¹^ORCID,Carrión‐Penagos Julián¹^ORCID,Chen Yu Fen⁶,Parrish Todd⁶,Zhou Xiaohong Joe⁷^ORCID,Koenig James I.⁸,Shenkar Robert¹,Stadnik Agnieszka¹,Koskimäki Janne¹,Dimov Alexey⁹,Turley Dallas⁹,Carroll Timothy⁹,Awad Issam A.¹

Affiliation:

1. Neurovascular Surgery Program, Section of Neurosurgery, Department of SurgeryUniversity of Chicago Medicine and Biological Sciences Chicago Illinois USA

2. Department of NeurologyMayo Clinic Rochester Minnesota USA

3. Department of RadiologyMayo Clinic Rochester Minnesota USA

4. Department of RadiologyUniversity of New Mexico Albuquerque New Mexico USA

5. Department of NeurologyUniversity of New Mexico Albuquerque New Mexico USA

6. Department of RadiologyNorthwestern University, Feinberg School of Medicine Chicago Illinois USA

7. Center for MR Research and Department of RadiologyUniversity of Illinois at Chicago Chicago Illinois USA

8. National Institute of Neurological Disorders and Stroke Bethesda Maryland USA

9. Department of Diagnostic RadiologyUniversity of Chicago Medicine and Biological Sciences Chicago Illinois USA

Funder

National Institute of Neurological Disorders and Stroke

Sigrid Juséliuksen Säätiö

Publisher

Wiley

Subject

Radiology Nuclear Medicine and imaging

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jmri.26927

Reference29 articles.

1. Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel

2. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study

3. Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data

4. Vascular permeability and iron deposition biomarkers in longitudinal follow‐up of cerebral cavernous malformations;Girard R;J Neurosurg

5. Dynamic Permeability and Quantitative Susceptibility

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. How to accurately quantify brain magnetic susceptibility in the context of Parkinson's disease: Validation on phantoms and healthy volunteers at 1.5 and 3 T;NMR in Biomedicine;2024-07-12

2. Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling;Stroke;2024-01

3. Pharmacokinetic Analysis of Enhancement-Constrained Acceleration (ECA) reconstruction-based high temporal resolution breast DCE-MRI;PLOS ONE;2023-06-15

4. Cavernous Angioma Symptomatic Hemorrhage (CASH) Trial Readiness II: Imaging Biomarkers and Trial Modeling;2023-06-05

5. Quantitative Susceptibility Mapping: Translating an Investigative Research Tool into High Volume Clinical Diagnostic Imaging;Diagnostics;2022-11-26